For engineers specifying UV-C disinfection systems, this wavelength difference has real consequences. The choice between 265nm and 280nm AlGaN LEDs affects system cost, thermal design, and whether the device can actually hit its inactivation targets within a reasonable power budget.
Head-to-head: 265nm vs 280nm UV-C LED
| Factor | 265nm UV-C LED | 280nm UV-C LED |
|---|---|---|
| Germicidal Action Index | ~1.0 (peak) | ~0.45 |
| Typical Wall-Plug Efficiency | 3-6% | 8-15% |
| AlN in AlGaN Active Layer | ~65-72% Al fraction | ~50-55% Al fraction |
| Commercial Output (per emitter) | 10-50 mW optical | 50-200 mW optical |
| Volume Cost (per module) | $50-150 | $20-60 |
| Effective Germicidal Flux (1W in) | ~35-60 mW eq. | ~36-67 mW eq. |
| Primary Substrate | AlN (expensive) | AlN or sapphire |
| Best Application | Water treatment, precision dose | Surface/air disinfection, cost-sensitive |
DNA absorption: why 265nm has the physics advantage
UV-C germicidal action works through photon absorption by nucleic acids. Thymine and cytosine bases in DNA absorb ultraviolet photons most strongly at 260-265nm, which is the energy level required to form cyclobutane pyrimidine dimers. Those dimers block DNA replication and kill or inactivate pathogens.
At 280nm, you are still in damaging UV territory, but the DNA absorption cross-section drops sharply. The germicidal action spectrum, a curve that normalizes effectiveness relative to the 265nm peak, shows roughly a 55% drop in photon effectiveness at 280nm. A 280nm system must deliver more than twice the optical dose to match what a 265nm source does to the same pathogen population.
The EPA ultraviolet radiation research program documents inactivation dose requirements for common waterborne pathogens across the UV-C band. For Cryptosporidium parvum, the dose required for 3-log inactivation at 280nm runs more than double the 265nm figure. For E. coli the ratio is somewhat better, but still decisively favors the shorter wavelength.
That wavelength-to-dose relationship is why 265nm is the standard choice for drinking water treatment and pharmaceutical manufacturing, where dose margins are tight and regulatory frameworks were built around 254nm mercury lamp data.
Efficiency gap: where 280nm fights back
280nm has a real efficiency advantage rooted in semiconductor physics. AlGaN LEDs at 265nm require roughly 65-72% aluminum fraction in the active layer. At those concentrations, p-type magnesium doping is difficult, crystal defect density rises, and electron-hole recombination efficiency falls. Commercial 265nm devices land at 3-6% wall-plug efficiency.
At 280nm, the required aluminum fraction drops to around 50-55%. Lower Al content produces better crystal quality and more efficient charge transport. Commercial 280nm LEDs routinely hit 8-15% wall-plug efficiency. Some research devices have exceeded 20% at this wavelength.
For a detailed breakdown of why this gap exists and what materials science is needed to close it, the quantum efficiency bottleneck analysis covers the AlGaN physics in detail.
Effective germicidal flux: running the numbers
- 265nm, 5% WPE, 1W input: 50 mW optical x 1.0 germicidal index = 50 mW effective germicidal flux
- 280nm, 10% WPE, 1W input: 100 mW optical x 0.45 germicidal index = 45 mW effective germicidal flux
- Conclusion: At typical efficiencies, 265nm delivers slightly more effective germicidal output per watt of electrical input, even though 280nm generates more raw photons
- Caveat: If 280nm efficiency reaches 15% (achievable now with premium devices), the calculation inverts: 150 mW x 0.45 = 67.5 mW vs 50 mW for 265nm
Cost and commercial availability in 2026
280nm modules are cheaper and produce more optical power per device. Seoul Viosys, Crystal IS, and Nichia all offer 280nm modules with 100-200 mW output at below $40 per module in volume. Equivalent 265nm devices from the same vendors produce 30-80 mW and cost $60-150 per module.
The substrate cost difference makes this worse. Deep 265nm LEDs need aluminum nitride substrates to minimize lattice mismatch with the high-Al AlGaN active layer. AlN substrates run 10-15x the cost of sapphire. At 280nm, sapphire works for many designs, which brings substrate cost down significantly.
The gap is narrowing. AlN substrate production has scaled as UV-C markets expanded, and several manufacturers now offer 265nm devices at prices that would have seemed unreachable in 2020. But for cost-sensitive applications, 280nm still enters at a meaningfully lower price point.
Thermal management differs too. The thermal packaging challenges for UV-C LEDs are serious at both wavelengths, but 265nm devices dump proportionally more waste heat per mW of useful output because of lower efficiency. Dense 265nm arrays need more aggressive heatsinking than an equivalent 280nm setup.
Choosing the right wavelength for your application
The selection is a system-level calculation, not a spec sheet comparison. The scenarios below show where each wavelength has a clear edge.
Choose 265nm when:
- Water treatment or flow-through systems: High dose requirements and established regulatory frameworks based on 254nm mercury lamp data favor the 265nm efficiency advantage
- Pharmaceutical or sterile manufacturing: Dose precision matters more than component cost when batch failures are expensive
- Replacing 254nm mercury lamps: Existing validation data transfers more directly to 265nm than to 280nm, reducing revalidation burden
- Minimum module count: If physical space limits the number of emitters, 265nm delivers more germicidal action per device
Choose 280nm when:
- Surface or air disinfection: Shorter exposure cycles and less stringent dose requirements make the cost advantage decisive
- Consumer or mid-tier devices: Bill-of-materials pressure makes 280nm the practical choice for water bottles, phone sanitizers, and similar products
- High optical power needed quickly: 280nm technology delivers higher output per emitter at lower cost, reaching required irradiance faster at lower system cost
- Pathogens with broad UV sensitivity: For organisms showing minimal wavelength-dependent sensitivity within the 260-290nm range, 280nm efficiency advantages matter more
Which wavelength wins
Neither is universally better. The 265nm advantage is real at the photon level, and DNA absorption physics will not change. But the semiconductor limitations of high-Al AlGaN mean 265nm devices carry efficiency and cost penalties that affect real system budgets.
Run the dose calculation for your specific application and pathogen targets. Convert optical power to effective germicidal flux using the action spectrum index. If 265nm delivers the required dose at a lower total system cost, use it. If 280nm closes the dose gap with fewer dollars, that is the right call.
If you have not done that calculation yet, start with how UV-C dose and pathogen inactivation are measured. The wavelength choice is only as good as the dose requirement it is designed around.